logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

William B Blanchard

This inventor holds 9 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1976-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William B Blanchard. Retrieved from https://idiyas.com/inventor/william-b-blanchard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:

goldMedal9 out of 4,517 
 
Eli Lilly and Company
 patents

Years Active: 1976-1996

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5574169 - Substituted pyrazolidin-3-one derivatives (1996-11-12),
2. 5399708 - Pyrazolidin-3-one derivatives (1995-03-21),
3. 5095107 - Process for cleavage of esters during the production of cephalosporins (1992-03-10),
4. 4133816 - Preparation of (1979-01-09),
5. 4115403 - Preparation of (1978-09-19),
6. 4054583 - Process for converting (1977-10-18),
7. 4054582 - Process for converting cis-hexahydrodibenzo[b,d]pyran-9-ones to (1977-10-18),
8. 4054581 - Preparation of (1977-10-18),
9. 3943126 - Process for acylating a 7-aminocephalosporin (1976-03-09),

Title: The Innovations of William B. Blanchard

Introduction

William B. Blanchard is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diseases of the central nervous system. With a total of nine patents to his name, Blanchard's work exemplifies innovation and dedication to improving healthcare.

Latest Patents

Among his latest patents are the "Substituted pyrazolidin-3-one derivatives" and "Pyrazolidin-3-one derivatives." Both inventions provide an enantiomerically selective process and intermediates for preparing certain 4,5-disubstituted pyrazolidinones. These compounds are particularly useful for treating diseases of the central nervous system, showcasing Blanchard's commitment to advancing medical science.

Career Highlights

Blanchard is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its research and development in innovative therapies. His work at Eli Lilly has allowed him to contribute to groundbreaking research that has the potential to change lives.

Collaborations

Throughout his career, Blanchard has collaborated with esteemed colleagues such as Charles W. Ryan and Thomas Charles Britton. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of new pharmaceutical solutions.

Conclusion

William B. Blanchard's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of central nervous system diseases, making him a valuable asset to the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…